Research & Development Cell

From Ideas to Impact

- Clinical Research
- Statistical Consultation
- Public Health Research
- Healthcare Analytics
- Research Trainings & Internships

Catalyzing Ideas, Igniting Progress: Caritas R & D at the Forefront.

The Research in Caritas Hospital was started in 2001. The department has successfully completed around 50 research studies. The department provides research support for all the doctors, faculties and students in our institutes. The centre provides statistical consultation and Research Methodology supports for researchers within and outside the institution. Various students from institutions across India join us for their research internship programs.

We work along with brightest minds in the world through sponsored studies. We contribute to the growth of science using in house research projects by our faculties. Our institute promotes research by providing intra-mural grants for brightest ideas in the institute.

Scope of Services
  • Clinical Research & Registries
  • Epidemiological Studies
  • Systematic Reviews
  • Statistical Analysis
  • Healthcare Analytics
  • Data Science
  • Research Methodology
  • Research Training

Ongoing Studies

 

Study Name
Investigators

Edoxaban For Intracranial Hemorrhage Survivors With Atrial Fibrillation – (ENRICH-AF)

Dr Joseph Sebastian,
Dr Deepak Davidson


A factorial randomized trial of structured physical activity training and brief cognitive behavioral therapy for depression and self management for prevention of repeat hospitaaaal admission and death among acute decompensated heart failure patients.

Dr Johny Joseph,
Dr Deepak Davidson


Team-Based collaborative care model, Faciliated by a mahealth enabled and Trained Nurse, for Management of Heart Failure in India

Dr Johny Joseph,
Dr Deepak Davidson


A prospective, active control, open-label, multi-centre, randomized clinical trial comparing BioMime Branch - Sirolimus Eluting Coronary Side Branch Stent System vs. Xience family of Everolimus Eluting Coronary Stent System to evaluate safety and performance in patients with de novo coronary bifurcation lesions

Dr Deepak Davidson,
Dr Johny Joseph


A prospective, post –marketing , multi-centre, study to evaluate safety and performance of the Evermime 50-50µm Evorolimus Eluting Coronary Stent System (EES) in the treatment of patients with de novo coronary artery lesions

Dr Deepak Davidson,
Dr Johny Joseph


Ongoing Studies

 

Study Name
Investigators

Edoxaban For Intracranial Hemorrhage Survivors With Atrial Fibrillation – (ENRICH-AF)

Dr Joseph Sebastian,
Dr Deepak Davidson


A factorial randomized trial of structured physical activity training and brief cognitive behavioral therapy for depression and self management for prevention of repeat hospitaaaal admission and death among acute decompensated heart failure patients.

Dr Johny Joseph,
Dr Deepak Davidson


Team-Based collaborative care model, Faciliated by a mahealth enabled and Trained Nurse, for Management of Heart Failure in India

Dr Johny Joseph,
Dr Deepak Davidson


A prospective, active control, open-label, multi-centre, randomized clinical trial comparing BioMime Branch - Sirolimus Eluting Coronary Side Branch Stent System vs. Xience family of Everolimus Eluting Coronary Stent System to evaluate safety and performance in patients with de novo coronary bifurcation lesions

Dr Deepak Davidson,
Dr Johny Joseph


A prospective, post –marketing , multi-centre, study to evaluate safety and performance of the Evermime 50-50µm Evorolimus Eluting Coronary Stent System (EES) in the treatment of patients with de novo coronary artery lesions

Dr Deepak Davidson,
Dr Johny Joseph


Completed Studies

 

Study Name
Investigators

A Prospective, Multi-Center Registry to assess Everolimus-Eluting Coronary Stent System (PROMUS Element™) for Coronary Revascularization in an Indian Population of Unrestricted Patients

Dr Deepak Davidson,
Dr Johny Joseph


“Diabetes in India – Nutrition guidelines study (DINGS) for review and approval”

Dr Remya Paul,
Dr Johny Joseph


AMR-01-01-0019 - A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled,and Parallel–Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events with EPA – Intervention Trial)

Dr Johny Joseph,
Dr Deepak Davidson


“The International Polycap Study 3” (TIPS 3) – A randomized double-blind placebo-controlled trial for the evaluation of a polycap, low dose aspirin and vitamin D supplementation in primary prevention.

Dr Deepak Davidson,
Dr Johny Joseph


A Phase 3b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Effect of Dalcetrapib 600 mg on Cardiovascular (CV) Events in Adult Patients with Stable Coronary Heart Disease (CHD), CHD Risk Equivalents or at Elevated Risk for Cardiovascular Disease (CVD)

Dr Johny Joseph


Completed Studies

 

Study Name
Investigators

A Prospective, Multi-Center Registry to assess Everolimus-Eluting Coronary Stent System (PROMUS Element™) for Coronary Revascularization in an Indian Population of Unrestricted Patients

Dr Deepak Davidson,
Dr Johny Joseph


“Diabetes in India – Nutrition guidelines study (DINGS) for review and approval”

Dr Remya Paul,
Dr Johny Joseph


AMR-01-01-0019 - A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled,and Parallel–Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events with EPA – Intervention Trial)

Dr Johny Joseph,
Dr Deepak Davidson


“The International Polycap Study 3” (TIPS 3) – A randomized double-blind placebo-controlled trial for the evaluation of a polycap, low dose aspirin and vitamin D supplementation in primary prevention.

Dr Deepak Davidson,
Dr Johny Joseph


A Phase 3b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Effect of Dalcetrapib 600 mg on Cardiovascular (CV) Events in Adult Patients with Stable Coronary Heart Disease (CHD), CHD Risk Equivalents or at Elevated Risk for Cardiovascular Disease (CVD)

Dr Johny Joseph


Top Collaborators

St.John's
Novartis-Logo 1
Meril
MG Unibersity
Hamilton Health Science
Medical Science
Abbott
Eversana
Batra-Hospital
cucebo
Amarin.png
Biotronik.png
Bristol.png
Boehringer
Cadila
Cardiological Society
Lilly.png
Glenmark.png
GSK
Reliance.png
Wyeth.png

Connect with Caritas Research & Development Cell

For enquiries, collaborations, and research support, reach out to our dedicated team at research@caritashospital.org or call us at 0481-2790025(Extn- 6041)